Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Latisha Heinlen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The American Journal of the Medical Sciences|August 11, 2010
Clostridium difficile infectionLatisha Heinlen, Jimmy D Ballard
Advances in Chronic Kidney Disease|November 18, 2019
Lupus Nephritis: Duration of Therapy and Possibility of WithdrawalLatisha Heinlen, Eliza F Chakravarty
Rheumatic Diseases Clinics of North America|April 10, 2017
Reproductive Health Screening in Women with Autoimmune DiseasesLatisha Heinlen, Eliza F Chakravarty
Journal of Medical Virology|May 23, 2007
EBNA1 expression in a lung transplant recipient with hypocomplementemic urticarial vasculitis syndromeMalin A M Berggren, Latisha Heinlen, Asa Isaksson, et al.
The New England Journal of Medicine|March 30, 2026
A Phase 3 Trial of Brepocitinib in DermatomyositisRuth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The American Journal of the Medical Sciences|August 11, 2010
Clostridium difficile infectionLatisha Heinlen, Jimmy D Ballard
Advances in Chronic Kidney Disease|November 18, 2019
Lupus Nephritis: Duration of Therapy and Possibility of WithdrawalLatisha Heinlen, Eliza F Chakravarty
Rheumatic Diseases Clinics of North America|April 10, 2017
Reproductive Health Screening in Women with Autoimmune DiseasesLatisha Heinlen, Eliza F Chakravarty
Journal of Medical Virology|May 23, 2007
EBNA1 expression in a lung transplant recipient with hypocomplementemic urticarial vasculitis syndromeMalin A M Berggren, Latisha Heinlen, Asa Isaksson, et al.
The New England Journal of Medicine|March 30, 2026
A Phase 3 Trial of Brepocitinib in DermatomyositisRuth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, et al.
Pageof 1